{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T16:13:40Z","timestamp":1774023220611,"version":"3.50.1"},"reference-count":35,"publisher":"American Medical Association (AMA)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"<jats:sec id=\"ab-zoi260111-4\">\n                    <jats:title>Importance<\/jats:title>\n                    <jats:p>The clinical utility of the comprehensive laboratory and medical investigations currently recommended for children with pediatric acute-onset neuropsychiatric syndrome (PANS) remains unclear. Notably, comparisons with relevant psychiatric control patients without suspected immunologic pathogenesis are lacking.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi260111-5\">\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To evaluate whether currently recommended laboratory investigations differentiate children with PANS from children with idiopathic obsessive-compulsive disorder (OCD) and\/or tic disorders and whether the full set of recommended medical investigations identify underlying somatic conditions in children with PANS.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi260111-6\">\n                    <jats:title>Design, Setting, and Participants<\/jats:title>\n                    <jats:p>This case-control study recruited children (aged 4-18 years) with PANS and children with idiopathic OCD and\/or tic disorders (control group) from specialist PANS and OCD clinics in Stockholm, Sweden, between January 1, 2020, and September 19, 2023. The data analyses were performed between June 16, 2024, and August 19, 2025.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi260111-7\">\n                    <jats:title>Main Outcomes and Measures<\/jats:title>\n                    <jats:p>Following published PANS guidelines, assessments included 56 laboratory variables from blood and throat cultures. Additional data from cerebrospinal fluid analysis, brain magnetic resonance imaging, and electroencephalography were available for a subsample of the PANS group. Laboratory findings were compared between the PANS and control groups.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi260111-8\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Among 109 participants, the PANS group included 51 children (mean [SD] age, 10.2 [3.4] years; 34 boys [66.7%], and the control group included 58 children (mean [SD] age, 13.6 [3.1] years; 29 boys [50.0%]). Nearly all participants had at least 1 abnormal laboratory finding (44 [86.3%] in the PANS group, 56 [96.6%] in the control group), with no significant between-group differences. Most participants in the PANS group had 3 or more abnormal laboratory findings, while most in the control group had 4 or more. One participant with PANS was diagnosed with celiac disease; another showed electroencephalographic signs of neuroinflammatory activity without a definite diagnosis prior to the PANS assessment. Incidental, nonactionable findings were frequent.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi260111-9\">\n                    <jats:title>Conclusions and Relevance<\/jats:title>\n                    <jats:p>In this case-control study of children with PANS and idiopathic OCD and\/or tic disorders, abnormal laboratory findings were common in both groups and did not differ significantly. The full set of recommended medical investigations rarely identified underlying somatic conditions in children with PANS. These findings question the clinical utility of the comprehensive and costly medical investigations currently recommended for children with suspected PANS.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2026.2618","type":"journal-article","created":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T15:30:23Z","timestamp":1774020623000},"page":"e262618","source":"Crossref","is-referenced-by-count":0,"title":["Recommended Medical Investigations in Pediatric Acute-Onset Neuropsychiatric Syndrome"],"prefix":"10.1001","volume":"9","author":[{"given":"Sara","family":"Vasiljevic","sequence":"first","affiliation":[{"name":"Centre for Psychiatry Research, Department of Clinical Neuroscience, Karolinska Institutet and Stockholm Health Care Services, Region Stockholm, Stockholm, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Malin E.","family":"Winerdal","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden"},{"name":"Clinical Immunology and Transfusion Medicine Unit, Karolinska University Hospital, Stockholm, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ronny","family":"Wickstr\u00f6m","sequence":"additional","affiliation":[{"name":"Neuropediatric Unit, Department of Women\u2019s and Children\u2019s Health, Karolinska Institutet, Stockholm, Sweden"},{"name":"Neuropediatric Unit, Astrid Lindgren Children\u2019s Hospital, Karolinska University Hospital, Stockholm, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eva","family":"Hesselmark","sequence":"additional","affiliation":[{"name":"Centre for Psychiatry Research, Department of Clinical Neuroscience, Karolinska Institutet and Stockholm Health Care Services, Region Stockholm, Stockholm, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Mataix-Cols","sequence":"additional","affiliation":[{"name":"Centre for Psychiatry Research, Department of Clinical Neuroscience, Karolinska Institutet and Stockholm Health Care Services, Region Stockholm, Stockholm, Sweden"},{"name":"Department of Clinical Sciences, Lund University, Lund, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Max","family":"Winerdal","sequence":"additional","affiliation":[{"name":"Division of Child and Adolescent Psychiatry, Uppsala Academic Hospital, Uppsala, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Malin","family":"Ek Sigerud","sequence":"additional","affiliation":[{"name":"Child and Adolescent Psychiatry Specialist Outpatient Care, Stockholm Health Care Services, Region Stockholm, Stockholm, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Selma","family":"Idring Nordstr\u00f6m","sequence":"additional","affiliation":[{"name":"Centre for Psychiatry Research, Department of Clinical Neuroscience, Karolinska Institutet and Stockholm Health Care Services, Region Stockholm, Stockholm, Sweden"},{"name":"Child and Adolescent Psychiatry Specialist Outpatient Care, Stockholm Health Care Services, Region Stockholm, Stockholm, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristina","family":"Tedroff","sequence":"additional","affiliation":[{"name":"Neuropediatric Unit, Department of Women\u2019s and Children\u2019s Health, Karolinska Institutet, Stockholm, Sweden"},{"name":"Child and Adolescent Psychiatry Specialist Outpatient Care, Stockholm Health Care Services, Region Stockholm, Stockholm, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10","published-online":{"date-parts":[[2026,3,20]]},"reference":[{"issue":"2","key":"zoi260111r1","doi-asserted-by":"publisher","first-page":"8","DOI":"10.4172\/2161-0665.1000113","article-title":"From research subgroup to clinical syndrome: modifying the PANDAS criteria to describe PANS (pediatric acute-onset neuropsychiatric syndrome).","volume":"2","author":"Swedo","year":"2012","journal-title":"Pediatr Ther"},{"issue":"2","key":"zoi260111r2","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1176\/ajp.155.2.264","article-title":"Pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections: clinical description of the first 50 cases.","volume":"155","author":"Swedo","year":"1998","journal-title":"Am J Psychiatry"},{"key":"zoi260111r3","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.2147\/NDT.S362202","article-title":"Pediatric acute-onset neuropsychiatric syndrome: current perspectives.","volume":"19","author":"Gagliano","year":"2023","journal-title":"Neuropsychiatr Dis Treat"},{"issue":"12","key":"zoi260111r4","doi-asserted-by":"publisher","first-page":"3153","DOI":"10.1111\/apa.15875","article-title":"Clinical guidance for diagnosis and management of suspected pediatric acute-onset neuropsychiatric syndrome in the Nordic countries.","volume":"110","author":"Pfeiffer","year":"2021","journal-title":"Acta Paediatr"},{"issue":"1","key":"zoi260111r5","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1089\/cap.2014.0084","article-title":"Clinical evaluation of youth with pediatric acute-onset neuropsychiatric syndrome (PANS): recommendations from the 2013 PANS Consensus Conference.","volume":"25","author":"Chang","year":"2015","journal-title":"J Child Adolesc Psychopharmacol"},{"issue":"7","key":"zoi260111r6","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1089\/cap.2016.0148","article-title":"Clinical management of pediatric acute-onset neuropsychiatric syndrome: part II-use of immunomodulatory therapies.","volume":"27","author":"Frankovich","year":"2017","journal-title":"J Child Adolesc Psychopharmacol"},{"issue":"7","key":"zoi260111r7","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1089\/cap.2016.0151","article-title":"Clinical management of pediatric acute-onset neuropsychiatric syndrome: part III-treatment and prevention of infections.","volume":"27","author":"Cooperstock","year":"2017","journal-title":"J Child Adolesc Psychopharmacol"},{"issue":"1","key":"zoi260111r8","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1038\/s41398-021-01700-4","article-title":"Immunological causes of obsessive-compulsive disorder: is it time for the concept of an \u201cautoimmune OCD\u201d subtype?","volume":"12","author":"Endres","year":"2022","journal-title":"Transl Psychiatry"},{"key":"zoi260111r9","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2023-077564","article-title":"All cause and cause specific mortality in obsessive-compulsive disorder: nationwide matched cohort and sibling cohort study.","volume":"384","author":"Fern\u00e1ndez de la Cruz","year":"2024","journal-title":"BMJ"},{"key":"zoi260111r10","doi-asserted-by":"publisher","DOI":"10.1016\/j.neubiorev.2022.104602","article-title":"Morbidity and mortality in obsessive-compulsive disorder: a narrative review.","volume":"136","author":"Fern\u00e1ndez de la Cruz","year":"2022","journal-title":"Neurosci Biobehav Rev"},{"issue":"7","key":"zoi260111r11","doi-asserted-by":"publisher","first-page":"1652","DOI":"10.1038\/mp.2017.215","article-title":"A total-population multigenerational family clustering study of autoimmune diseases in obsessive-compulsive disorder and Tourette\u2019s\/chronic tic disorders.","volume":"23","author":"Mataix-Cols","year":"2018","journal-title":"Mol Psychiatry"},{"issue":"7","key":"zoi260111r12","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2024.21688","article-title":"Development of autoimmune diseases among children with pediatric acute-onset neuropsychiatric syndrome.","volume":"7","author":"Ma","year":"2024","journal-title":"JAMA Netw Open"},{"key":"zoi260111r13","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.bbi.2023.09.016","article-title":"Cerebrospinal fluid findings in patients with obsessive-compulsive disorder, Tourette syndrome, and PANDAS: a systematic literature review.","volume":"115","author":"Pankratz","year":"2024","journal-title":"Brain Behav Immun"},{"issue":"2","key":"zoi260111r14","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1176\/appi.ajp.157.2.281","article-title":"MRI assessment of children with obsessive-compulsive disorder or tics associated with streptococcal infection.","volume":"157","author":"Giedd","year":"2000","journal-title":"Am J Psychiatry"},{"issue":"5","key":"zoi260111r15","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1017\/S1092852918001268","article-title":"Neuroanatomical features and its usefulness in classification of patients with PANDAS.","volume":"24","author":"Cabrera","year":"2019","journal-title":"CNS Spectr"},{"issue":"5","key":"zoi260111r16","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2020.4063","article-title":"Association of pediatric acute-onset neuropsychiatric syndrome with microstructural differences in brain regions detected via diffusion-weighted magnetic resonance imaging.","volume":"3","author":"Zheng","year":"2020","journal-title":"JAMA Netw Open"},{"issue":"4","key":"zoi260111r17","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1089\/cap.2018.0087","article-title":"PANDAS and PANS: clinical, neuropsychological, and biological characterization of a monocentric series of patients and proposal for a diagnostic protocol.","volume":"29","author":"Gamucci","year":"2019","journal-title":"J Child Adolesc Psychopharmacol"},{"issue":"2","key":"zoi260111r18","doi-asserted-by":"publisher","first-page":"75","DOI":"10.3390\/neurosci1020007","article-title":"PANS\/PANDAS: clinical experience in IVIG treatment and state of the art in rehabilitation approaches.","volume":"1","author":"Pavone","year":"2020","journal-title":"NeuroSci"},{"issue":"2","key":"zoi260111r19","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1007\/s10578-021-01135-4","article-title":"A two-to-five year follow-up of a pediatric acute-onset neuropsychiatric syndrome cohort.","volume":"53","author":"Gromark","year":"2022","journal-title":"Child Psychiatry Hum Dev"},{"issue":"20","key":"zoi260111r20","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1001\/jama.2013.281053","article-title":"World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects.","volume":"310","author":"World Medical Association","year":"2013","journal-title":"JAMA"},{"issue":"12","key":"zoi260111r21","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1016\/j.ijsu.2014.07.013","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies.","volume":"12","author":"von Elm","year":"2014","journal-title":"Int J Surg"},{"issue":"1","key":"zoi260111r23","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1080\/1047322X.1990.10389587","article-title":"Estimation of average concentration in the presence of nondetectable values.","volume":"5","author":"Hornung","year":"1990","journal-title":"Appl Occup Environ Hyg"},{"key":"zoi260111r25","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.jneuroim.2017.09.002","article-title":"Biomarkers for diagnosis of pediatric acute neuropsychiatric syndrome (PANS) - sensitivity and specificity of the Cunningham panel.","volume":"312","author":"Hesselmark","year":"2017","journal-title":"J Neuroimmunol"},{"issue":"1","key":"zoi260111r26","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1089\/cap.2014.0081","article-title":"Multidisciplinary clinic dedicated to treating youth with pediatric acute-onset neuropsychiatric syndrome: presenting characteristics of the first 47 consecutive patients.","volume":"25","author":"Frankovich","year":"2015","journal-title":"J Child Adolesc Psychopharmacol"},{"issue":"8","key":"zoi260111r27","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1089\/cap.2018.0127","article-title":"Establishing a pediatric acute-onset neuropsychiatric syndrome clinic: baseline clinical features of the pediatric acute-onset neuropsychiatric syndrome cohort at Karolinska Institutet.","volume":"29","author":"Gromark","year":"2019","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"zoi260111r28","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1007102","article-title":"Pitfalls in complement analysis: a systematic literature review of assessing complement activation.","volume":"13","author":"Brandwijk","year":"2022","journal-title":"Front Immunol"},{"issue":"6","key":"zoi260111r29","doi-asserted-by":"publisher","DOI":"10.1002\/jcla.22420","article-title":"Age-specific pediatric reference ranges for immunoglobulins and complement proteins on the Optilite automated turbidimetric analyzer.","volume":"32","author":"Garcia-Prat","year":"2018","journal-title":"J Clin Lab Anal"},{"key":"zoi260111r30","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2023.1216282","article-title":"Immunological characterization of an Italian PANDAS cohort.","volume":"11","author":"Leonardi","year":"2024","journal-title":"Front Pediatr"},{"issue":"8","key":"zoi260111r31","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1089\/cap.2018.0151","article-title":"Clinical-serological characterization and treatment outcome of a large cohort of Italian children with pediatric autoimmune neuropsychiatric disorder associated with streptococcal infection and pediatric acute neuropsychiatric syndrome.","volume":"29","author":"Lepri","year":"2019","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"zoi260111r32","doi-asserted-by":"publisher","DOI":"10.3389\/fnbeh.2024.1342486","article-title":"Cerebrospinal fluid characteristics of patients presenting for evaluation of pediatric acute-neuropsychiatric syndrome.","volume":"18","author":"Pooni","year":"2024","journal-title":"Front Behav Neurosci"},{"key":"zoi260111r33","doi-asserted-by":"publisher","DOI":"10.1016\/j.neubiorev.2025.106202","article-title":"Characteristics of cerebrospinal fluid in autism spectrum disorder - a systematic review.","volume":"174","author":"Srivastava","year":"2025","journal-title":"Neurosci Biobehav Rev"},{"issue":"8","key":"zoi260111r34","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1002\/jdn.10228","article-title":"How does brain structure and function on MRI differ in children with autism spectrum disorder, developmental coordination disorder, and\/or attention deficit hyperactivity disorder?","volume":"82","author":"Kangarani-Farahani","year":"2022","journal-title":"Int J Dev Neurosci"},{"issue":"6","key":"zoi260111r35","doi-asserted-by":"publisher","first-page":"1882","DOI":"10.3390\/jcm14061882","article-title":"Electroencephalography in autism spectrum disorder.","volume":"14","author":"Hankus","year":"2025","journal-title":"J Clin Med"},{"key":"zoi260111r24","volume-title":"Principal Component Analysis","author":"Jolliffe","year":"2002","edition":"2nd ed"},{"key":"zoi260111r22","unstructured":"Karolinska Universitetslaboratoriet. Karolinska Universitetssjukhuset. Accessed October 31, 2024. https:\/\/www.karolinska.se\/lab"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2846736\/vasiljevic_2026_oi_260111_1773430281.13839.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T15:30:24Z","timestamp":1774020624000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2846736"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,20]]},"references-count":35,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3,2]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2026.2618","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,20]]}}}